La catena delle opzioni mostra i dati chiave delle opzioni azionarie di Applied Graphene Materials PLC a vari prezzi di esercizio e date di scadenza. I trader utilizzano queste informazioni per analizzare potenziali operazioni e valutare il sentiment del mercato per Applied Graphene Materials PLC..

Applied Graphene Materials PLC (OTC:APGMF) Azioni, Catena delle Opzioni

Applied Graphene Materials PLC

Needham analyst Laura Martin initiates coverage on MNTN (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MNTN#NYSE">MNTN</a>) with a Buy rating and announces Price Target of $25.

News

Price Target

Initiation

Analyst Ratings

MNTN

Needham Initiates Coverage On MNTN with Buy Rating, Announces Price Target of $25

SAGE

Trading Halt: Halted at 6:55:00 a.m. ET - Trading Halt: Halt News Pending

Ascendiant Capital analyst Edward Woo maintains Duos Technologies Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DUOT#NASDAQ">DUOT</a>) with a Buy and raises the price target from $9 to $11.

DUOT

Ascendiant Capital Maintains Buy on Duos Technologies Group, Raises Price Target to $11

<a href="https://www.globenewswire.com/Tracker?data=s1sqEipjS-Pbns36XpcoDIauzklQ8ObpOSSdPTUee-iIFIVy-B1UzKBnkS8NvKsGKA7M0Oi02cSnvC-lDW6cARKguAfgKol5WOXRHWzFncdeS5lNG9Cws4CcP5gOOUbJGxcotnNVOLs32_MW5gsbk_x6cu3CYSwAJZ5r-sQ3MruX2qLKYrI-aUnHHGrBzyWR2n9b1exWS4O3NSjrpNwo0i5QCz4X5ETpAKEzGx3pLfY=">Pharvaris</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PHVS#NASDAQ">PHVS</a>), a late-stage biopharmaceutical company developing novel, oral bradykinin B2 receptor antagonists to help address unmet needs of those living with bradykinin-mediated diseases such as hereditary angioedema (HAE) and acquired angioedema due to C1 inhibitor deficiency (AAE-C1INH), today announced a summary of data that were presented at the European Academy of Allergy and Clinical Immunology (EAACI) Congress 2025.
"Pharvaris embraced the opportunity to engage in scientific exchange with the HAE thought leader community during EAACI as we presented data supporting the differentiated profile of deucrictibant for the prophylactic and on-demand treatment of bradykinin-mediated angioedema attacks," said Berndt Modig, Chief Executive Officer of Pharvaris. "Building on our R&amp;D call from last week, we shared data demonstrating the potential for deucrictibant to address the unmet needs of people living with bradykinin-mediated angioedema beyond HAE-1/2. Deucrictibant showed sustained attack reduction and improved quality of life measures in the randomized portion of the CHAPTER-1 study, which was maintained in the open-label extension study, as well as early-onset symptom relief and complete symptom resolution in a single dose in most attacks in our ongoing RAPIDe-2 on-demand long-term extension study. Finally, RAPIDe-3 is the first and only phase 3 on-demand study that will explore ‘end-of-progression' as a new pre-specified endpoint, which is particularly meaningful for people living with HAE. Together with the outcomes from other study endpoints, we will be able to assess the full impact of deucrictibant on an HAE attack from start to end."

PHVS

Pharvaris Shares New Data on Oral Treatment for Rare Swelling Disorder at Global Allergy Conference

A Tesla Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) Model 3 was reportedly hit by a train after it got stuck on the railroad tracks while in FSD or Full Self-Driving mode.
What Happened: The driver, who was able to escape the car before it was hit by a train, said that the Tesla was in "self-driving mode", Electrek reported <a href="https://electrek.co/2025/06/16/tesla-on-self-driving-stuck-train-track-hit-train/">on </a>Monday.
The vehicle sustained minor damages, with the left mirror reportedly snapping off following the incident. Emergency services temporarily halted all rail operations to clear the vehicle with a crane, the report suggests.
Tesla did not immediately respond to <a href="http://pro.benzinga.com">Benzinga&#8217;s</a> request for comment. 
Why It Matters: The incident follows Musk's claims that Tesla vehicles would be able to drive themselves to customers' houses straight from the factory after June 28. The comments were in line with a tentative <a href="https://www.benzinga.com/markets/tech/25/06/45876375/elon-musk-says-tesla-robotaxi-rides-begin-june-22-in-austin-full-self-driving-to-enable-home-delivery-by-june-28-were-being-super-paranoid">June 22 launch </a>for the EV giant's highly anticipated Robotaxi launch in Austin.
However, critics have raised concerns about the technology, with Gerber Kawasaki's CEO and Co-Founder, Ross Gerber, saying the technology needs a <a href="https://www.benzinga.com/markets/tech/25/06/45764059/ross-gerber-says-tesla-has-lot-of-work-to-do-on-fsd-ahead-of-robotaxi-launch-waymos-are-way-better">lot of work.</a>
Elsewhere, CEO Elon Musk's Cybercab ambitions also <a href="https://www.benzinga.com/markets/tech/25/06/45942936/elon-musks-cybercab-ambitions-just-got-a-boost-as-nhtsa-eases-regulations-for-autonomous-vehicles">got a major boost </a>as the National Highway Traffic Safety Administration, or NHTSA, announced a series of updates to regulations, making Autonomous vehicles exempt from some safety standards.
Tesla was also officially named as an AV operator in Austin by the local authorities, which led to Musk hailing the city a better option to launch the robotaxi than LA, where multiple Alphabet Inc.'s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOG#NASDAQ">GOOG</a>) <a href="https://www.benzinga.com/markets/tech/25/06/45853688/tesla-robotaxi-rival-waymo-suspends-services-in-downtown-la-following-vandalism-during-anti-ice-protests">Waymo robotaxis were vandalized</a>.
<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="192" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/16063525/tsla-June-16-2025-1-1024x192.jpg" alt="" class="wp-image-950528" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/16063525/tsla-June-16-2025-1-1024x192.jpg 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/16063525/tsla-June-16-2025-1-300x56.jpg 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/16063525/tsla-June-16-2025-1-768x144.jpg 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/16063525/tsla-June-16-2025-1-1536x288.jpg 1536w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/16063525/tsla-June-16-2025-1.jpg 1560w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Tesla scores well on Momentum, Quality and Growth metrics, but offers poor Value. For more such insights, sign up for<a href="https://www.benzinga.com/premium/ideas/benzinga-edge-2#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound"> Benzinga Edge Stock Rankings</a> today!
Check out more of Benzinga's Future Of Mobility coverage by<a href="https://www.benzinga.com/topic/mobility"> following this link.</a>
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/news/politics/25/06/45943245/trump-says-he-was-amazed-that-tesla-ceo-elon-musk-endorsed-him-despite-his-anti-ev-stance">Trump Says He Was &#8216;Amazed&#8217; That Tesla CEO Elon Musk Endorsed Him Despite His Anti-EV Stance</a></li>
</ul>
Image vIa Shutterstock

GOOG

GOOGL

TSLA

Tesla Model 3 On FSD Mode Struck By Train After Getting Trapped On Railroad Tracks: Report

AIRS

AirSculpt Improves Capital Structure With $10M Debt Paydown Following Successful Stock Offering

Ascendiant Capital analyst Edward Woo maintains Surgepays (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SURG#NASDAQ">SURG</a>) with a Buy and raises the price target from $8.75 to $9.

SURG

Ascendiant Capital Maintains Buy on Surgepays, Raises Price Target to $9

Sarepta Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SRPT#NASDAQ">SRPT</a>) stock experienced a steep decline of approximately 40% in premarket trading on Monday following a sobering safety update for its <a href="https://www.benzinga.com/general/health-care">Duchenne muscular dystrophy (DMD)</a> gene therapy, Elevidys.
What Happened: On Sunday, Sarepta provided a safety update regarding Elevidys (delandistrogene moxeparvovec-rokl), the only approved gene therapy for patients with Duchenne muscular dystrophy, and steps the company is taking to strengthen the safety profile in non-ambulatory patients.
These steps follow a second reported case of acute liver failure (ALF), <a target="_blank" href="https://www.benzinga.com/pressreleases/25/06/b45940036/sarepta-provides-safety-update-for-elevidys-and-initiates-steps-to-strengthen-safety-in-non-ambula" rel="noreferrer noopener">resulting in death</a>.
In March,&nbsp;Sarepta Therapeutics reported a patient death following treatment with Elevidys, having suffered <a target="_blank" href="https://www.benzinga.com/25/03/44376919/sarepta-therapeutics-reports-patient-death-post-elevidys-gene-therapy-treatment-stock-plunges" rel="noreferrer noopener">acute liver failure</a>.
The cases of ALF to date have both occurred in non-ambulatory (patients who cannot walk independently) individuals with Duchenne.
Sarepta and Roche Holdings AG (OTC:<a class="ticker" href="https://www.benzinga.com/stock/RHHBY#OTC">RHHBY</a>) temporarily halted several <a target="_blank" href="https://www.benzinga.com/25/04/44634689/sareptaroche-suspend-elevidys-gene-therapy-trials-in-europe-after-patient-death" rel="noreferrer noopener">clinical studies in April</a>.
During its first-quarter earnings release, Sarepta revised its 2025 total net product revenues guidance to $2.3-$2.6 billion <a target="_blank" href="https://www.benzinga.com/25/05/45261806/sarepta-therapeutics-stock-sinks-on-gloomy-forecast-analysts-cut-price-forecasts" rel="noreferrer noopener">from $2.9-$3.1 billion</a>.
William Blair writes that the revised guidance primarily concerns delayed Elevidys turnaround times.
Also Read: <a href="https://www.benzinga.com/general/biotech/25/05/45393806/ten-year-data-from-roches-breast-cancer-trial-shows-perjeta-based-regimen-cuts-death-risk-by-17" target="_blank" rel="noreferrer noopener">Ten-Year Data From Roche&#8217;s Breast Cancer Trial Shows Perjeta-Based Regimen Cuts Death Risk By 17%</a>
Key Safety Initiatives
As part of a comprehensive review of safety data, Sarepta is taking proactive steps to mitigate the risk of acute liver failure in non-ambulatory patients.
A panel will evaluate data and assess the company&#8217;s proposed regimen, which includes sirolimus and is supported by preclinical data demonstrating the effectiveness of additional immunosuppression in moderating liver enzyme elevations, a key factor in mitigating potential safety events.
Sarepta will share the panel&#8217;s recommendations with the U.S. Food &amp; Drug Administration (FDA), and implementation of any new regimen will be subject to FDA guidance and allowance.
In the meantime, Sarepta is temporarily suspending shipments of Elevidys for non-ambulatory patients.
For ambulatory patients, no treatment <a target="_blank" href="https://www.roche.com/investors/updates/inv-update-2025-06-15" rel="noreferrer noopener">changes</a> are being proposed and the current practice of administering corticosteroids before and after Elevidys infusion and post-treatment monitoring remains the same.
Sarepta has voluntarily paused dosing in the ENVISION clinical study (also known as Study SRP-9001-303).
ENVISION is a global, randomized, double-blind, placebo-controlled trial evaluating Elevidys in older ambulatory and non-ambulatory Duchenne muscular dystrophy patients.
In the U.S., it serves as the confirmatory trial required under the FDA&#8217;s accelerated approval pathway for non-ambulatory patients.
Price Action: SRPT stock is trading lower by 42.0% to $21.00 during the premarket session at last check Monday.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/biotech/25/06/45797348/early-wins-regenxbios-gene-therapy-helps-duchenne-patients-walk-stronger-longer" target="_blank" rel="noreferrer noopener">Early Wins: RegenXBio&#8217;s Gene Therapy Helps Duchenne Patients Walk Stronger, Longer</a></li>
</ul>
Photo via Shutterstock

Biotech

Health Care

Movers

General

RHHBY

SRPT

Sarepta Therapeutics Stock Plummets Over 40% On Second Fatal Case Linked To Its Gene Therapy

VEON Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VEON#NASDAQ">VEON</a>), a global digital operator ("VEON" or the "Company"), announces that it will shortly commence the third phase of its previously announced share buyback program with respect to the Company's American Depositary Shares ("ADSs"). This third phase of the buyback will be in the amount of up to USD 35 million.&nbsp;
The third phase of the share buyback program is being launched after the successful completion of the second phase on May 21, 2025. Cumulatively, the two earlier phases of the program have resulted in the repurchase of 1.43 million ADSs at an average repurchase price of USD 45.59 per ADS. VEON had announced a share buyback program of up to USD 100 million on August 1, 2024.&nbsp;
The Company continues to believe that its ADSs are undervalued relative to its operational performance and strategic potential. With the buyback program, VEON aims to optimize shareholder value and strengthen its financial position for future opportunities.&nbsp;
The buybacks will be conducted on the open market pursuant to a 10b5-1 plan signed with a registered broker-dealer, and in compliance with Rule 10b-18.
VEON is also considering options to raise external financing through a sub-benchmark &nbsp;private placement of bonds, with a tenor of up to approximately four years (the "Notes"), with the goal of supporting the Company's strategic initiatives and enhancing its financial flexibility. The Notes, if issued, will be issued by VEON Midco B.V. and guaranteed by VEON Amsterdam B.V. This evaluation is a part of VEON's ongoing capital planning effort and discussions with potential institutional investors are in progress.

Buybacks

VEON

VEON Launches $35M Buyback Phase as It Eyes Undervalued Shares and Boosts Shareholder Value

Follow on order will bring the airline's total commitment to 235 GTF-powered aircraft, including already delivered aircraft
PARIS, June 16, 2025 /PRNewswire/ -- Pratt &amp; Whitney, an RTX (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RTX#NYSE">RTX</a>) business, and Frontier Airlines (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ULCC#NASDAQ">ULCC</a>) today announced the selection of Pratt &amp; Whitney GTF&#x2122; engines to power 91 Airbus A321neo aircraft, with the first of these aircraft currently scheduled for delivery in Q4 2026. Pratt &amp; Whitney will also provide Frontier Airlines with engine maintenance through a long-term EngineWise&#xAE; Comprehensive service agreement. This latest order will bring the airline's total commitment to 235 GTF-powered A320neo family aircraft, including already delivered aircraft.

ULCC

RTX's Pratt & Whitney And Frontier Airlines Announce Selection Of Pratt & Whitney GTF Engines To Power 91 Airbus A321neo Aircraft

International Game Technology PLC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IGT#NYSE">IGT</a>) announced today that it recently signed a new, three-year sports betting technology agreement with Boyd Gaming Corporation. Under the terms of the agreement, IGT's award-winning PlaySports platform will continue powering Boyd Gaming's retail and mobile sports betting offering in Nevada through August 2028. The new agreement builds on IGT and Boyd Gaming's long-standing sports betting technology partnership that started in 2018.
<a href="https://mma.prnewswire.com/media/453980/IGT_Logo.html">IGT</a>) is a global leader in gaming. We deliver entertaining and responsible gaming experiences for players across all channels and regulated segments, from Lotteries and Gaming Machines to Sports Betting and Digital. Leveraging a wealth of compelling content, substantial investment in innovation, player insights, operational expertise, and leading-edge technology, our solutions deliver unrivaled gaming experiences that engage players and drive growth. We have a well-established local presence and relationships with governments and regulators in more than 100 jurisdictions around the world, and create value by adhering to the highest standards of service, integrity, and responsibility. IGT has approximately 11,000 employees. For more information, please visit www.igt.com." alt="IGT (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IGT#NYSE">IGT</a>) is a global leader in gaming. We deliver entertaining and responsible gaming experiences for players across all channels and regulated segments, from Lotteries and Gaming Machines to Sports Betting and Digital. Leveraging a wealth of compelling content, substantial investment in innovation, player insights, operational expertise, and leading-edge technology, our solutions deliver unrivaled gaming experiences that engage players and drive growth. We have a well-established local presence and relationships with governments and regulators in more than 100 jurisdictions around the world, and create value by adhering to the highest standards of service, integrity, and responsibility. IGT has approximately 11,000 employees. For more information, please visit www.igt.com."&gt;

IGT Extends Sports Betting Deal With Boyd Gaming to Keep Powering Nevada's Retail and Mobile Wagers Through 2028

Health care providers can begin prescribing the 12.5 mg and 15 mg vials on July 7, and shipments to patients will begin in early August. With the addition of these doses, every strength of Zepbound vial will be available for $499/month or less ($349 for the 2.5 mg starter dose) to any eligible adult with obesity and a valid prescription, regardless of insurance.

Large Cap

Eli Lilly Announces That The Highest Approved Doses Of Zepbound (Tirzepatide)—12.5 mg And 15 mg—Will Soon Be Available In Single-dose Vials For $499 Per Month Through LillyDirect's Self Pay Pharmacy Solutions And The Zepbound Self Pay Journey Program

<ul>
<li>Expands and integrates Eaton's offerings in next-generation aerospace solutions</li>
<li>Expect accretive margins and growth</li>
</ul>
Intelligent power management company Eaton (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ETN#NYSE">ETN</a>) today announced it has signed an agreement to acquire Ultra PCS Limited from the Cobham Ultra Group. Ultra PCS's innovative solutions for safety and mission critical aerospace systems will augment Eaton's portfolio in both military and civilian aircraft. We expect Ultra PCS's strong growth position on high-margin business to be accretive to Eaton. Under the terms of the agreement, Eaton will pay $1.55 billion for Ultra PCS. The transaction, which is subject to customary closing conditions and regulatory approvals, is expected to close in the first half of 2026.
Ultra PCS Limited, headquartered in Cheltenham, U.K. and with operations in the U.K. and U.S., produces electronic controls, sensing, stores ejection and data processing solutions, enabling mission success for global aerospace customers in the air and on the ground. Ultra PCS estimates 2025 sales of approximately $240 million.

Eaton To Acquire Ultra PCS From Cobham Ultra Group For $1.55B

Mr. Ming Ni resigned as the Chief Operation Officer (the "COO") of Metalpha Technology Holding Limited (the "Company"), effective on the same day. Mr. Ming Ni confirmed that his resignation was due to personal reasons and was not the result of any dispute or disagreements with the Company on any matter relating to the Company's operations, policies or practices.
The board of directors of the Company (the "Board") approved the appointment of Ms. Xiaosi Zhang as the new COO, effective on the same date.
In addition, on the same date, Mr. Limin Liu has proposed to resign as a member of the Board, effective as of June 30, 2025. Mr. Limin Liu confirmed that his resignation was due to personal reasons and was not the result of any dispute or disagreements with the Company on any matter relating to the Company's operations, policies or practices.
Ms. Xiaosi Zhang has over 15 years of leadership experience in global financial institutions especially human resource area which perfectly fits the Company's high demand of talents for its global expansion. Ms. Zhang served as the Executive Director, Head of Risk Control, Head of Executive Office at China Development Bank International Investment Limited. Before that, Ms. Zhang was HR &amp; Administration Manager at HuaTai Financial Holdings. Ms. Zhang obtained her bachelor's degree in Journalism from Nanjing University and a master's degree in Communication from Hong Kong Baptist University.

Management

MATH

Metalpha Appoints Xiaosi Zhang as COO After Ming Ni Resigns for Personal Reasons

ReNew Energy Glb (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RNW#NASDAQ">RNW</a>) reported quarterly earnings of $0.10 per share which beat the analyst consensus estimate of $0.07 by 42.86 percent. This is a 400 percent increase over earnings of $0.02 per share from the same period last year. The company reported quarterly sales of $340.00 million which beat the analyst consensus estimate of $291.80 million by 16.52 percent. This is a 56.68 percent increase over sales of $217.00 million the same period last year.

Earnings

Earnings Beats

ReNew Energy Glb Q4 EPS $0.10 Beats $0.07 Estimate, Sales $340.00M Beat $291.80M Estimate

United Nations High Commissioner for Human Rights Volker Turk urged U.S. authorities Monday to respect peaceful assembly rights and avoid military force against protesters opposing President Donald Trump&#8216;s immigration crackdown.
The warning comes as federal tensions escalate with 4,700 troops deployed in Los Angeles amid eight days of demonstrations.
What Happened: Turk told the U.N. Human Rights Council in Geneva that authorities should &#8220;refrain from any resort to military force when civilian authorities are capable of maintaining public order,&#8221; reported Reuters.
His statement follows an unprecedented deployment of U.S. Marines <a href="https://www.benzinga.com/news/politics/25/06/45938132/us-marines-detain-civilian-in-los-angeles-amid-immigration-protests-first-known-incident-of-its-kind-report">who detained civilian Marcos Leao</a>, an Army veteran, at the Wilshire Federal Building Friday.
The incident marked the first known active-duty military detention of a civilian in Los Angeles. Marines used zip ties to restrain Leao before transferring him to Department of Homeland Security custody.
Military Northern Command confirmed active-duty forces can temporarily detain individuals under specific conditions before immediate transfer to civilian law enforcement.
Currently, 200 Marines and 2,000 National Guard members protect federal assets in Los Angeles, with 500 additional Marines and 2,000 Guard troops expected.
Immigration and Customs Enforcement operations <a href="https://www.benzinga.com/news/events/25/06/45878983/us-cities-brace-for-escalating-immigration-protests-los-angeles-enforces-curfew-national-guard-deployed-amid-trump-crackdown">arrest 2,000 immigration offenders daily</a>, exceeding the 311 daily average under former President Joe Biden.
California Governor Gavin Newsom sued to block military deployment, calling it an assault on democracy. A federal appeals court allowed Trump to maintain National Guard control, marking the first federal activation without gubernatorial consent since 1965. Los Angeles imposed downtown curfews with 197 arrests in one day.
See Also: <a href="https://www.benzinga.com/markets/tech/25/06/45944333/zoom-ceo-eric-yuan-dismisses-work-life-balance-work-is-life-life-is-work-with-one-important-caveat">Zoom CEO Eric Yuan Dismisses Work-Life Balance: &#8216;Work Is life, Life Is Work&#8217;—With One Important Caveat</a>
Why It Matters: The Trump administration <a href="https://www.benzinga.com/news/politics/25/06/45939400/trump-administration-enforces-long-dormant-world-war-ii-era-alien-registration-act">reactivated the World War II-era Alien Registration Act,</a> requiring 3.2 million unregistered immigrants to register with the government or face prosecution under the &#8220;mass self-deportation&#8221; strategy. The Department of Homeland Security received 47,000 registrations since April enforcement began.
California Attorney General Rob Bonta warned federal troop deployment could violate the 1878 Posse Comitatus Act restricting military involvement in civilian law enforcement. Former President Barack Obama defended DACA recipients Sunday, stating families &#8220;<a href="https://www.benzinga.com/news/politics/25/06/45943372/obama-calls-for-dignity-in-immigration-enforcement-as-ice-crackdown-escalates">are being demonized and treated as enemies&#8221;.</a>
Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/news/politics/25/06/45944099/trump-tax-plan-targets-unfair-foreign-levies-risks-capital-war-say-experts">Trump Tax Plan Targets &#8216;Unfair&#8217; Foreign Levies, Risks &#8216;Capital War,&#8217; Say Experts</a></li>
</ul>
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Photo courtesy: Maxim Elramsisy / Shutterstock.com

Politics

UN Human Rights Chief Urges US To Avoid Using Military Force Against Anti-Trump Protesters, Calls For Protection Of Peaceful Assembly Rights

Fox Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FOX#NASDAQ">FOX</a>) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FOXA#NASDAQ">FOXA</a>) Fox Advertising on Monday <a href="https://www.benzinga.com/pressreleases/25/06/n45943816/fox-advertising-launches-enhanced-brand-storytelling-program-with-strategic-investment-in-the-ligh" target="_blank" rel="noreferrer noopener">announced a strategic investment</a> in The Lighthouse (part of the Whalar Group), the innovative studio and campus space explicitly designed for Creators to collaborate and develop content.
The financial terms of the deal remain undisclosed.
The investment will also support the launch of Fox&#8217;s new IP development initiative, which aims to fuel Creator-led franchises across its content portfolio.
Also Read: <a href="https://www.benzinga.com/markets/tech/25/06/45876224/youtube-contributed-55-billion-to-us-gdp-new-report-reveals-the-creator-economy-is-just-getting-started-says-ceo-neal-mohan">YouTube Contributed $55 Billion To US GDP, New Report Reveals: &#8216;The Creator Economy Is Just Getting Started,&#8217; Says CEO Neal Mohan</a>
The strategic investment will strengthen Fox&#8217;s commitment to Creator-powered innovation and content creation.
Unveiled at the&nbsp;Cannes Lions International Festival of Creativity, Fox, and The Lighthouse&#8217;s future-forward strategic relationship, together with the launch of Fox&#8217;s new IP development initiative, will bring together the art of storytelling, brand integration, and new media experiences and will allow advertisers to collaborate with Creators around brand sponsorships and advertising inventory tied to new properties, as well as access to a pipeline of Creator-led properties designed for maximum cultural relevance and creative impact.
Fox held $4.82 billion in <a target="_blank" href="https://www.benzinga.com/pressreleases/25/05/n45344835/fox-reports-third-quarter-fiscal-2025-revenues-of-4-37-billion-net-income-of-354-million-and-adjus" rel="noreferrer noopener">cash and equivalents</a> as of March 31, 2025.
Fox stock surged 59% in the last 12 months. The company reported <a target="_blank" href="https://www.benzinga.com/news/earnings/25/05/45350789/fox-q3-win-65-ad-surge-driven-by-super-bowl-tubi-growth" rel="noreferrer noopener">third-quarter revenue</a> of $4.37 billion, up from $3.45 billion a year ago, beating the&nbsp;analyst&nbsp;consensus estimate of $4.16 billion.&nbsp;
Adjusted net income was $507 million, or $1.10 per share, beating the&nbsp;analyst&nbsp;consensus estimate&nbsp;of&nbsp;$0.90.&nbsp;It was&nbsp;$520 million or $1.09 per share a year ago.
Price Action: FOXA stock is trading lower by 0.04% to $49.28 premarket at last check on Monday.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/analyst-stock-ratings/analyst-color/25/06/45930835/iphone-sales-rebound-in-china-but-apples-next-move-could-be-risky" target="_blank" rel="noreferrer noopener">iPhone Sales Rebound In China, But Apple&#8217;s Next Move Could Be Risky</a></li>
</ul>
Photo by KinoMasterskaya via Shutterstock

FOXA

Fox Backs The Lighthouse To Develop Creator-Led Franchises

Ascendiant Capital analyst Lucas Ward maintains LiqTech International (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LIQT#NASDAQ">LIQT</a>) with a Buy and raises the price target from $3.4 to $3.6.

LIQT

Ascendiant Capital Maintains Buy on LiqTech International, Raises Price Target to $3.6

An Air India Boeing 787-8 en route to New Delhi from Hong Kong made an unexpected return to Hong Kong on Monday after an in-flight irregularity prompted safety concerns.
What Happened: Flight AI315 departed Hong Kong at around 12:20 p.m. local time and started climbing toward its cruising altitude. Reuters reports that at 22,000 feet, the crew identified a possible malfunction and decided to reverse course. It landed safely back at Hong Kong International Airport at approximately 1:15 PM.
Air India stated: "AI315 returned to Hong Kong shortly after take-off due to a technical issue. The flight landed safely … and is undergoing checks as a matter of abundant precaution."
According to the Airport Authority Hong Kong, the plane requested emergency standby shortly after takeoff. The Dreamliner involved in the incident is seven years old.
See Also: <a href="https://www.benzinga.com/news/politics/25/06/45944099/trump-tax-plan-targets-unfair-foreign-levies-risks-capital-war-say-experts">Trump Tax Plan Targets &#8216;Unfair&#8217; Foreign Levies, Risks &#8216;Capital War,&#8217; Say Experts</a>
Why It Matters: The incident comes on the heels of a <a href="https://www.benzinga.com/markets/25/06/45911791/boeing-dreamliner-carrying-over-200-passengers-crashes-shortly-after-takeoff-near-indias-ahmedabad-b">tragic crash</a> involving another Air India Dreamliner, which killed 241 passengers in Ahmedabad, India, last week. In response to the accident, Boeing Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BA#NYSE">BA</a>) <a href="https://www.benzinga.com/trading-ideas/movers/25/06/45910788/boeing-stock-drops-after-dreamliner-crash-just-weeks-following-15-month-high">stock fell after rising to a 15-month high</a>.
The company has been at the center of controversy following a <a href="https://www.benzinga.com/markets/equities/25/06/45940768/boeings-troubled-2000s-from-a-sweetheart-1-1b-deal-before-deadly-air-india-crash-to-stranding-astronauts-at-iss-and-airline-crashes">series of incidents</a> involving its aircraft. Despite public backlash, it recently struck a deal with the Department of Justice to <a href="https://www.benzinga.com/news/legal/25/05/45594990/doj-offers-boeing-deal-to-avoid-criminal-charges-over-737-max-crashes">avoid prosecution</a> by agreeing to pay more than $1.1 billion over two deadly crashes in 2018 and 2019 that claimed 346 lives.
Monday's incident in Hong Kong is likely to add to Boeing's woes, as India considers <a href="https://www.benzinga.com/markets/equities/25/06/45919464/boeing-faces-fresh-turmoil-as-india-mulls-787-8-grounding-after-fatal-crash-ceo-kelly-cancels-pa">grounding the country&#8217;s Boeing 787-8</a> fleet temporarily.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/macro-economic-events/25/06/45943707/us-economy-to-face-pretty-limited-impact-from-israel-iran-airstrikes-with-only-a-tiny-bit-recession-risk-say-economists">US Economy To Face &#8216;Pretty Limited&#8217; Impact From Israel-Iran Airstrikes, With Only A &#8216;Tiny Bit&#8217; Recession Risk, Say Economists</a></li>
</ul>
Photo courtesy: Vytautas Kielaitis / Shutterstock.com

Equities

Air India Boeing 787-8 Returns To Hong Kong Mid-Flight Due To Technical Issue, Prompting Fresh Scrutiny Of Airline's Safety Protocols

Stellantis NV (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/STLA#NYSE">STLA</a>) has begun trials for battery swapping technology in the Fiat 500e all-electric hatchback, which could offer a fully-charged battery in 5 minutes.
What Happened: The company, which owns various brands like Jeep, Chrysler, Fiat, Peugeot and more, is conducting test runs for the technology in the Spanish capital Madrid with a fleet of 40 vehicles, Autocar reported <a href="https://www.autocar.co.uk/car-news/technology/fiat-trialling-tech-fully-charges-500e-just-five-minutes">on</a> Friday.
The 500e fleet belongs to Fiat's Free2Move fleet, while the battery swapping trial is being undertaken in collaboration with battery swapping company Ample, the report said.
"We are dedicated to thoroughly testing and analysing this concept in real-world conditions and aiming to expand it to private customers soon," Fiat CEO Olivier François said, hinting that it could be offered to owners if the trial goes well.
Why It Matters: The news comes in as Stellantis has been making moves in the sector, with the company having recently shared that the Dodge Charger EV in 2026 will be powered by <a href="https://www.benzinga.com/tech/25/04/45061846/stellantis-announces-breakthrough-solid-state-battery-with-factorial-energy-company-says-technology-will-debut-in-2026-demo-fleet">a solid-state battery</a>.
The U.S. auto industry is struggling with supply chain issues as well as curbs on rare earth minerals and <a href="https://www.benzinga.com/news/politics/25/06/45854131/trump-says-hes-getting-good-reports-as-scott-bessent-led-delegation-expects-beijing-to-remove-rare-earth-export-curbs">magnets imposed by China</a>. However, U.S. President Donald Trump had shared that a deal has been approved pending Xi Jinping's decision.
Amid the trade tensions, Trump had also highlighted that he may <a href="https://www.benzinga.com/markets/tech/25/06/45919154/trump-says-he-may-hike-auto-tariffs-again-to-boost-domestic-production-the-higher-you-go-they-build-a-plant-here">hike the tariffs </a>on the automotive industry to boost domestic production. "I might go up with that tariff in the not too distant future. The higher you go, the more likely it is they build a plant here," Trump said.
Check out more of Benzinga's Future Of Mobility coverage by<a href="https://www.benzinga.com/topic/mobility"> following this link</a>.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/tech/25/06/45826735/china-grants-temporary-rare-earth-licenses-to-us-automakers-suppliers">China Grants Temporary Rare-Earth Licenses To US Automakers&#8217; Suppliers</a></li>
</ul>
Photo courtesy: rikstock / Shutterstock.com

Comments

Applied Graphene Materials PLC

Applied Graphene Materials PLC (APGMF) Opzioni

No option chain data available. Please try again later

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO